Title: Deep Learning-based CT Radiomics Predicts Prognosis of Unresectable Hepatocellular
Carcinoma Treated with TACE-HAIC combined with PD-1 Inhibitors and Tyrosine Kinase
Inhibitors
Version: 2 Date: 09 Oct 2024
Reviewer's report:
This retrospective study investigated a CT-based radiomics model to predict PFS of unresectable
hepatocellular carcinoma treated with TACE±HAIC combined with PD-1 Inhibitors and
tyrosine kinase inhibitors. The results are solid and support the conclusion. I would recommend
it for publication if the authors could improve the manuscript from the following aspects:
1. The language of the manuscript needs improvement. I found some grammar mistakes and
unprofessional terms.
2. The references need to be updated with the most recent literature in the field of combined
therapy.
3. The result will be more convincing with a larger sample size and longer follow-up time to
investigate whether the model can predict the OS.
Title: Deep Learning-based CT Radiomics Predicts Prognosis of Unresectable Hepatocellular
Carcinoma Treated with TACE-HAIC combined with PD-1 Inhibitors and Tyrosine Kinase
Inhibitors
Version: 2 Date: 09 Oct 2024
Reviewer's report:
This retrospective study investigated a CT-based radiomics model to predict PFS of unresectable
hepatocellular carcinoma treated with TACE±HAIC combined with PD-1 Inhibitors and
tyrosine kinase inhibitors. The results are solid and support the conclusion. I would recommend
it for publication if the authors could improve the manuscript from the following aspects:
1. The language of the manuscript needs improvement. I found some grammar mistakes and
unprofessional terms.
2. The references need to be updated with the most recent literature in the field of combined
therapy.
3. The result will be more convincing with a larger sample size and longer follow-up time to
investigate whether the model can predict the OS.
Please review this paper.
user
Title: Deep Learning-based CT Radiomics Predicts Prognosis of Unresectable Hepatocellular
Carcinoma Treated with TACE-HAIC combined with PD-1 Inhibitors and Tyrosine Kinase
Inhibitors
Version: 2 Date: 09 Oct 2024
Reviewer's report:
This retrospective study investigated a CT-based radiomics model to predict PFS of unresectable
hepatocellular carcinoma treated with TACE±HAIC combined with PD-1 Inhibitors and
tyrosine kinase inhibitors. The results are solid and support the conclusion. I would recommend
it for publication if the authors could improve the manuscript from the following aspects:
1. The language of the manuscript needs improvement. I found some grammar mistakes and
unprofessional terms.
2. The references need to be updated with the most recent literature in the field of combined
therapy.
3. The result will be more convincing with a larger sample size and longer follow-up time to
investigate whether the model can predict the OS.
assistant